Biologic drugs
Protalix develops plant-cell-made protein medicines for rare diseases and works with partners to bring those medicines to market, including treatments such as Fabry disease therapies and enzyme replacement products.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Protalix Biotherapeutics makes biologic medicines, especially replacement enzymes for rare genetic diseases. Its core technology grows therapeutic proteins in plant cells, not in the usual animal-cell factories, and the company turns that into finished drugs or drug candidates for rare-disease patients. Its best-known products are treatments for conditions such as Gaucher disease and Fabry disease, which are sold through partners and specialty drug channels.
The company makes money mainly in two ways: it sells approved medicines and it earns income from partnerships, licensing, and development deals with larger drug companies. Those partners help fund development, manufacturing, and global marketing, while Protalix keeps a role in the underlying technology and some commercial rights.
What makes Protalix different is its manufacturing platform. Instead of building a broad drug portfolio, it focuses on a small number of complex protein drugs that are hard to make with standard methods. That gives it a niche role in the rare-disease market, where the value is in the ability to produce specialized biologics reliably and to support partners that bring the drugs to patients.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more